ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Valogen Biosciences Limited

Valogen Biosciences Limited is an active company incorporated on 10 January 2018 with the registered office located in Kingsbridge, Devon. Valogen Biosciences Limited was registered 7 years ago.
Status
Active
Active since 5 years ago
Company No
11142238
Private limited company
Age
7 years
Incorporated 10 January 2018
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 24 November 2024 (9 months ago)
Next confirmation dated 24 November 2025
Due by 8 December 2025 (2 months remaining)
Last change occurred 9 months ago
Accounts
Submitted
For period 1 Feb31 Jan 2025 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 January 2026
Due by 31 October 2026 (1 year 1 month remaining)
Contact
Address
Upton Barton
South Milton
Kingsbridge
South Devon
TQ7 3JF
United Kingdom
Same address since incorporation
Telephone
01548 562023
Email
Unreported
People
Officers
4
Shareholders
13
Controllers (PSC)
1
Director • Farmer • British • Lives in England • Born in Apr 1969
Director • British • Lives in UK • Born in May 1968
Director • British • Lives in England • Born in Mar 1974
Director • British • Lives in England • Born in Nov 1960
Dr Peter Elliott Luebcke
PSC • British • Lives in UK • Born in May 1968
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Bell & Loxton LLP
Rachel Jane Bell is a mutual person.
Active
Curapel (Scotland) Limited
Dr Peter Elliott Luebcke is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2019–2025)
Period Ended
31 Jan 2025
For period 31 Jan31 Jan 2025
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
3
Same as previous period
Total Assets
£22.81K
Decreased by £57.28K (-72%)
Total Liabilities
-£29.62K
Increased by £8.24K (+39%)
Net Assets
-£6.82K
Decreased by £65.52K (-112%)
Debt Ratio (%)
130%
Increased by 103.19% (+387%)
Latest Activity
Full Accounts Submitted
4 Months Ago on 22 Apr 2025
Confirmation Submitted
9 Months Ago on 5 Dec 2024
Peter Elliott Luebcke (PSC) Appointed
11 Months Ago on 24 Sep 2024
Jon Bell (PSC) Resigned
11 Months Ago on 24 Sep 2024
Rachel Jane Bell Resigned
11 Months Ago on 24 Sep 2024
Jon Bell Resigned
11 Months Ago on 24 Sep 2024
Dr Peter Elliott Luebcke Appointed
11 Months Ago on 23 Sep 2024
Micro Accounts Submitted
1 Year 1 Month Ago on 6 Aug 2024
Confirmation Submitted
1 Year 9 Months Ago on 24 Nov 2023
Micro Accounts Submitted
2 Years Ago on 1 Sep 2023
Get Credit Report
Discover Valogen Biosciences Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Resolutions
Submitted on 17 Jul 2025
Statement of capital following an allotment of shares on 7 July 2025
Submitted on 15 Jul 2025
Total exemption full accounts made up to 31 January 2025
Submitted on 22 Apr 2025
Resolutions
Submitted on 18 Dec 2024
Cessation of Jon Bell as a person with significant control on 24 September 2024
Submitted on 11 Dec 2024
Notification of Peter Elliott Luebcke as a person with significant control on 24 September 2024
Submitted on 11 Dec 2024
Confirmation statement made on 24 November 2024 with updates
Submitted on 5 Dec 2024
Termination of appointment of Rachel Jane Bell as a director on 24 September 2024
Submitted on 24 Sep 2024
Termination of appointment of Jon Bell as a director on 24 September 2024
Submitted on 24 Sep 2024
Appointment of Dr Peter Elliott Luebcke as a director on 23 September 2024
Submitted on 23 Sep 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year